Clinical Trials for AML (Acute Myelogenous Leukemia)

Find clinical trials for aml (acute myelogenous leukemia). Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors

NCT ID: NCT06911710

This clinical trial is exploring a new treatment called CAR-T cell therapy for patients with certain types of blood cancers, including aggressive lymphomas, acute myeloid leukemia (AML), and multip...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tianjin, Tianjin, China

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients with Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT ID: NCT06859424

This clinical trial is studying the best way to prevent a condition called graft-versus-host disease (GVHD) in patients who receive stem cell transplants from unrelated donors. GVHD occurs when the...

Not yet recruiting

Phase: PHASE2 Type: interventional

Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade

NCT ID: NCT06874257

The clinical trial, titled "Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combined IDO1 Inhibition and PD-1 Blockade," is studying how a combination of two treatments—azaci...

Recruiting

Type: observational Locations: Bologna, , Italy

CD123-CD16-NK Cells Immunotherapy for AML

NCT ID: NCT06835140

This clinical trial is studying a new treatment for patients with a type of blood cancer called Acute Myeloid Leukemia (AML) that has come back or has not responded to previous treatments. The rese...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China

Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT

NCT ID: NCT06783790

This clinical trial is studying a combination of three medications—avapritinib, azacitidine, and venetoclax—for patients with relapsed acute myeloid leukemia (AML) after receiving a stem cell trans...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, , China

Efficacy of Venetoclax Combined with Intensive Chemotherapy in Different Subgroups of AML

NCT ID: NCT06635681

This clinical trial is looking at how well a medication called Venetoclax works when combined with intensive chemotherapy for patients with Acute Myelogenous Leukemia (AML). AML is a type of cancer...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions